法国关于遗传性血管的诊断和管理的协议
Isabelle Boccon-Gibod1, Olivier Fain2, Delphine Gobert2
1National reference center for angioedema (CREAK), Internal medicine department, Grenoble University Hospital, Grenoble, France.
La Revue de medecine interne
|October 30, 2025
概括
复发性血管 (AE) 的诊断和管理具有挑战性. 这项研究概述了法国针对布拉迪基宁介导遗传性血管瘤 (BK-HAE) 的方案,通过新的治疗方法改善了患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 血管生物学 血管生物学
背景情况:
- 复发性隔离性血管 (AE) 存在诊断和治疗方面的挑战,复杂的分类包括巨细胞介导和布拉迪基宁介导类型.
- 布拉迪基宁介导的遗传性血管 (BK-HAE),特别是C1抑制剂缺乏症 (HAE-C1INH),影响大约每5万个人的1个,并带有窒息和腹部紧急情况的风险.
- 疾病呈现受雌激素等因素的影响,女性的诊断依赖于C1抑制剂水平或基因检测突变 (F12,PLG,KNG1).
研究的目的:
- 提出法国国家诊断和管理布拉迪基宁介导遗传性血管 (BK-HAE) 的方案.
- 强调严格的临床方法在区分AE亚型和指导治疗策略方面的重要性.
- 突出最近的治疗进展对这些罕见疾病的预后的影响.
主要方法:
- 对血管子亚型国际分类的审查.
- 描述C1抑制剂缺乏和C1抑制剂正常遗传性血管的诊断标准.
- 管理策略的概述,包括患者教育和使用特定疗法.
主要成果:
- 该协议涉及AE的7个公认的子组,重点是BK-HAE.
- 诊断途径包括评估C1抑制剂水平和对特定突变进行遗传分析.
- 新的,有效的治疗方法显著改善了BK-HAE患者的预后.
结论:
- 法国协议为诊断和管理BK-HAE提供了一个结构化的方法.
- 早期和准确的诊断,加上患者教育和向治疗,对于改善生活质量和减少发病率至关重要.
- 治疗方面的进步为遗传性血管患者提供了更加乐观的前景.
关键词:
血管功能胀 血管功能胀天使使给了我一个.我是一个继承的天使.布拉迪基尼尼尼尼尼尼尼尼布拉迪基尼尼 (Bradykinine) 是一个非常有价值的品牌.这是一种C1抑制剂.这是一种C1抑制剂.在FXII中,我们可以看到FXII.遗传性血管腺 遗传性血管腺卡利克雷因 (Kallicréine) 是一种制剂.卡利克里恩是个可爱的人.在 PLG PLG 中.更多相关视频
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12.2K
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
12.2K
相关概念视频
01:26Angina IV: Management
230
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
230
01:21Rheumatic Heart Disease III: Medical Management
277
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:26Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
01:25Aortic Regurgitation III: Medical Management
385
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
385
01:26Nephrotic Syndrome II : Assessment and Medical Management
189
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
189